Philip Morris International Inc.(PM)
Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products that are sold in markets outside the United States. The company offers its smoke-free products under the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, HEETS FROM MARLBORO, Marlboro Dimensions, Marlboro HeatSticks, Parliament HeatSticks, and TEREA brands, as well as the KT&G-licensed brands, Fiit, and Miix. It also sells its products under the Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris brands. In addition, the company owns various cigarette brands, such as Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia; and Fortune and Jackpot in the Philippines. The company sells its smoke-free products in 71 markets. Philip Morris International Inc. was incorporated in 1987 and is headquartered in New York, New York.
Latest News & Analysis
Philip Morris's Zyn Gambit: Transformation Thesis Meets Market Scepticism
Philip Morris beat Q3 estimates yet traded down on cautious guidance. Can Zyn's momentum offset legacy tobacco decline?
Philip Morris Smoke-Free Transformation: Zyn and IQOS Growth
Philip Morris drives a smoke‐free transformation with strong Q4 earnings and robust growth in Zyn and IQOS amid evolving regulatory challenges.
Philip Morris International Navigates the Smoke-Free Future
In-depth analysis of PM’s Q4 earnings, innovative smoke-free strategies, and a shifting regulatory landscape impacting future growth.
PMI's Smoke-Free Future: Q4 Earnings, ZYN Growth & CAGNY 2025 Insights
An in-depth analysis of Philip Morris International’s transformation, Q4 earnings, and breakthrough developments in its smoke-free portfolio.
Philip Morris International: Smoke-Free Future at CAGNY 2025
Philip Morris International focuses on smoke-free future at CAGNY 2025, highlighting IQOS and ZYN growth amid regulatory challenges and market shifts.
Philip Morris International: Smoke-Free Revolution Drives Growth in 2025
Explore PMI’s robust Q4 2024 earnings, its groundbreaking shift to smoke-free products, and the regulatory challenges shaping its future.
Philip Morris International: Navigating the Smoke-Free Revolution in 2025
Philip Morris International navigates its smoke-free transformation, driven by IQOS and ZYN growth amid evolving regulations and market dynamics.
Philip Morris International: A Smoke-Free Future
Philip Morris International navigates a smoke-free future amid shifting investor sentiment and regulatory changes. IQOS and ZYN drive transformation. CAGNY conference insights.
Philip Morris International: Navigating Smoke-Free Future
Philip Morris International navigates a smoke-free future amidst market volatility, driven by IQOS and ZYN growth, regulatory hurdles, and dividend strategies.
Philip Morris: Intraday Update on Financial and Strategic Developments
Intraday update on Philip Morris, detailing financial performance, strategic shifts, and market dynamics with verified, real-time data.
Philip Morris (PM): Smoke-Free Strategy, Dividends, and Market Resilience
Philip Morris International navigates a smoke-free future with strategic shifts, dividend focus, and market resilience. A deep dive into PM's financials and strategic moves.
Philip Morris (PM): Smoke-Free Transformation and ZYN's Rise
PMI is transforming, shifting to smoke-free products like ZYN and IQOS. The company's financials are increasingly driven by these products, aiming for two-thirds of revenue from smoke-free sources by 2030.
Philip Morris (PM): Zyn's Rise, Dividend Concerns, Smoke-Free Future
Philip Morris International is transforming into a smoke-free company, driven by Zyn's popularity. High payout ratio and regulatory challenges pose risks, but growth prospects and defensive characteristics make it an interesting investment.
Philip Morris International: Smoke-Free Revolution & Investor Impact
Philip Morris International (PMI) is strategically transitioning to smoke-free products like IQOS and ZYN, demonstrating strong growth potential.
Philip Morris International's Strategic Pivot: Smoke-Free Dominance
Philip Morris International (PM) is aggressively shifting towards smoke-free products, with IQOS and ZYN driving significant revenue growth amid regulatory changes and illicit trade challenges.
Philip Morris International: Digital Transformation Fuels Smoke-Free Growth
Philip Morris International's bold digital transformation and IQOS expansion have propelled smoke-free product revenue to 44%, reaffirming its robust dividend commitment amidst evolving global regulations.
Philip Morris International's Strategic Pivot: Unpacking Growth, Dividends, and Financial Dynamics
Philip Morris International (PM) navigates a complex transition, showcasing robust smoke-free growth and strong cash flow despite profitability shifts and a high dividend payout.
PM Stock: Philip Morris International's Smoke-Free Pivot & Q1 2025 Earnings
Philip Morris International's Q1 2025 earnings beat, driven by smoke-free product growth and pricing power, signals a robust strategic pivot.
Philip Morris International Inc. Market Update: Smoke-Free Growth and Strategic Valuation Insights | Monexa AI
Philip Morris International drives growth with IQOS and ZYN, balancing elevated valuation and regulatory challenges in its strategic smoke-free pivot.
Philip Morris International Inc. (PM) Latest Market Analysis: Smoke-Free Growth Drives Premium Valuation
Philip Morris International's smoke-free product surge boosts revenue and margins, fueling premium valuation amid evolving regulatory landscape.
Philip Morris International Inc. (PM) Latest Market Analysis & Strategic Insights
Explore Philip Morris International's strategic shift to smoke-free products, financial performance, and valuation amid regulatory challenges in this detailed analysis.
Philip Morris International (PM) Q2 2025 Update: Strategic Growth in Smoke-Free Products Drives Financial Resilience
Philip Morris International's Q2 2025 outlook highlights robust smoke-free product growth, strong free cash flow, and international expansion, positioning it ahead in the tobacco sector.
Philip Morris International: Navigating Illicit Trade and Smoke-Free Growth
Philip Morris International navigates rising illicit trade in the EU while accelerating its shift to smoke-free products, impacting financials and strategic focus.
Philip Morris International's Strategic Pivot and Q2 2025 Financial Analysis | Monexa AI
Explore Philip Morris International's Q2 2025 results, smoke-free product growth, raised EPS guidance, and competitive positioning in the evolving tobacco industry.
Philip Morris International Inc. Q2 2025: Smoke-Free Growth Drives Financial Upside and Strategic Momentum
Philip Morris International's Q2 2025 surge in smoke-free products IQOS, ZYN, and VEEV fuels upward guidance, higher margins, and solid dividend sustainability.
Philip Morris International: ILUMA Rollout & Revenue Shift
Q2 shows smoke‑free products at **41%** of revenue. ILUMA and VEEV drive consumables growth and margin leverage; watch regulatory tax risk and elevated leverage.
Philip Morris International Inc. Q2 2025 Update: Smoke-Free Growth Amidst Revenue Challenges
Philip Morris International advances its smoke-free strategy with robust IQOS and ZYN growth despite Q2 2025 revenue misses and illicit trade challenges.
Philip Morris International: Stock Surge, Smoke-Free Growth in 2025
Philip Morris International's stock surge and strategic pivot to smoke-free products are key themes in 2025, navigating growth amid regulatory shifts and competition.
Philip Morris International (PM): Cash-Flow Strength, Smoke-Free Pivot, and Dividend Durability
Philip Morris posted +7.70% revenue growth to $37.88B in FY2024 while net income fell -9.60%; free cash flow surged +36.69% to $10.77B and net debt fell to $41.48B.
Philip Morris International: Smoke‑Free Growth, Margin Lift and the Dividend Trade-Off
PM’s smoke‑free rollout and cost savings drove **+7.71%** revenue growth in 2024 and **$10.77B** free cash flow, but high payout and leverage create a narrow margin for error.
Philip Morris International — Cash Flow, Margins and the Smoke‑Free Pivot
Philip Morris reported consecutive 2025 beats and its smoke‑free products now account for **41%** of revenues while FY2024 delivered **$10.77B** free cash flow.